Why the study?
Chronic kidney disease and coronary artery disease interact, with accelerated coronary disease and high cardiovascular mortality in patients with chronic kidney disease.
This review highlights the importance of comprehensive evidence-based management, including comorbidity control and lifestyle interventions, for patients with concurrent coronary artery disease and chronic kidney disease.
Answers are grounded in this paper and cite their sources.
May support integrated comorbidity management in CKD-CAD; leaves open rigorous trials on targeted interventions.
Chronic kidney disease impacts coronary artery disease and vice versa. Patients with chronic kidney disease develop coronary artery disease at accelerated rates, and cardiovascular disease is the most common cause of death in patients with chronic kidney disease. Optimal management of comorbidities affecting both diseases, such as diabetes, depression and hypertension, is paramount. In addition, adequate management of pain, quitting smoking and exercise counselling can all be targeted to improve outcomes and quality of life. This paper reviews the evidence-based management of the patient with both coronary artery disease and chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
Newman et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: